The COVID-19 Vaccine Advisory Committee will meet from noon to 2 p.m. (MT) on Friday, Jan. 22, via Webex.Read the full agenda.
Newsroom Articles
Showing 201–210 of 260 results
COVID-19 vaccine media briefing set for Tuesday
The Department of Health and Welfare (DHW) will hold a media briefing about COVID-19 vaccine in Idaho at 2:30 p.m. Tuesday, Jan. 19.
DHW expects 2-5 percent increase in weekly COVID-19 vaccine doses
The Department of Health and Welfare has learned today that Idaho will not see a large increase in COVID-19 vaccine doses from the previously announced release of second doses.
COVID-19 vaccine media briefing set for Tuesday
The Department of Health and Welfare (DHW) will hold a media briefing about COVID-19 vaccine in Idaho at 2:30 p.m. MT Tuesday, Jan. 12.
With more time at home this winter, Idahoans urged to test for radon gas
In Idaho, 2 in 5 tested homes across the state have higher-than-recommended radon levels.
Idaho COVID-19 Vaccine Advisory Committee to meet Friday
The COVID-19 Vaccine Advisory Committee will meet from noon to 2 p.m. (MT) on Friday, Jan. 8, via Webex. Agenda highlights include an update on vaccine in Idaho, adverse event reporting in Idaho, and priority subgroup clarification, among others.
COVID-19 vaccine media briefing set for Tuesday
Make a New Year’s resolution to quit tobacco for good! New resources to quit are available for people with behavioral health conditions
Studies show it may take several tries before you’re able to quit tobacco for good. Quitting can be challenging, but the right support for your quit journey increases your chances of quitting for good.
Healthcare workers and residents of long-term care facilities now receiving the COVID-19 vaccine
Idaho is in full swing getting vaccines out to Idahoans. As of today, Idaho has received 56,225 doses of COVID-19 vaccine.
Two severe allergic reactions reported after COVID-19 vaccination in Idaho
The Idaho Division of Public Health has received reports of two healthcare workers experiencing severe allergic reactions, also referred to as serious adverse events, after they received the Pfizer-BioNTech COVID-19 vaccine.